Gene Location [1]
DNA damage/repair

AACR GENIE data is not categorized as somatic or germline. To see GENIE data for this alteration, click here.

Biomarker-Directed Therapies

Significance of BRCA2 Mutation (germline) in Diseases

Breast Carcinoma +

Pancreatic Adenocarcinoma +

Primary Peritoneal Carcinoma +

Ovarian Carcinoma +

Fallopian Tube Carcinoma +

Malignant Solid Tumor +

Prostate Carcinoma +

Ovarian Undifferentiated Carcinoma +

Primary Peritoneal Serous Adenocarcinoma +

Ovarian Endometrioid Tumor +

High Grade Ovarian Serous Adenocarcinoma +

Pancreatic Carcinoma +

Prostate Adenocarcinoma +

Ovarian Mixed Epithelial Tumor +

Fallopian Tube Endometrioid Adenocarcinoma +

Fallopian Tube Transitional Cell Carcinoma +

Hereditary Breast And Ovarian Cancer Syndrome +

High Grade Fallopian Tube Serous Adenocarcinoma +

Ovarian Transitional Cell Carcinoma +

Melanoma +

Bladder Carcinoma +

Transitional Cell Carcinoma +

Endometrial Carcinoma +

Ovarian Mucinous Adenocarcinoma +

Esophageal Squamous Cell Carcinoma +

Malignant Uterine Neoplasm +

Colorectal Carcinoma +

Ovarian Endometrioid Adenocarcinoma +

Gastric Adenocarcinoma +

Head And Neck Carcinoma +

Malignant Ovarian Clear Cell Tumor +

Ductal Carcinoma In Situ +

Ovarian Clear Cell Tumor +

Non-Small Cell Lung Carcinoma +

Lung Carcinoma +

Adenocarcinoma Of The Gastroesophageal Junction +

Cancer +

Malignant Ovarian Epithelial Tumor +

Malignant Ovarian Serous Tumor +

Ovarian Serous Tumor +

Gallbladder Carcinoma +

Pancreatic Ductal Adenocarcinoma +

Invasive Breast Carcinoma +

Breast Adenocarcinoma +

Bile Duct Carcinoma +

Cervical Carcinoma +

Soft Tissue Sarcoma +

Low Grade Ovarian Serous Adenocarcinoma +

Malignant Ovarian Mixed Epithelial Tumor +

Breast Lobular Carcinoma In Situ +

Bronchogenic Carcinoma +

Fallopian Tube Clear Cell Adenocarcinoma +

Fallopian Tube Mucinous Adenocarcinoma +

Fallopian Tube Serous Adenocarcinoma +

Fallopian Tube Undifferentiated Carcinoma +

Low Grade Fallopian Tube Serous Adenocarcinoma +

Ovarian Clear Cell Adenocarcinoma +

Primary Peritoneal Clear Cell Carcinoma +

Primary Peritoneal Endometrioid Adenocarcinoma +

Primary Peritoneal High Grade Serous Adenocarcinoma +

Primary Peritoneal Low Grade Serous Adenocarcinoma +

Primary Peritoneal Serous Papillary Adenocarcinoma +

Primary Peritoneal Transitional Cell Carcinoma +

Primary Peritoneal Undifferentiated Carcinoma +


1. Hart R and Prlic A. Universal Transcript Archive Repository. Version uta_20180821. San Francisco CA: Github;2015. https://github.com/biocommons/uta

2. The UniProt Consortium. UniProt: a worldwide hub of protein knowledge. Nucleic Acids Research. 2019;47:D506-D515.

3. Liu X, Wu C, Li C, and Boerwinkle E. dbNSFP v3.0: A one-stop database of functional predictions and annotations for human nonsynonymous and splice site SNVs. Human Mutation. 2015;37:235-241.

Liu X, Jian X, and Boerwinkle E. dbNSFP: A lightweight database of human nonsynonymous SNPs and their functional predictions. Human Mutation. 2011;32:894-899.

4. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.

5. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.